Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study.

The difference of 9.1% in the SVR rates between the ≥ 25% and < 25% overreporting levels was highly significant ( p <.001).

also in 132,142 other papers

≥ 25% overreporting was significant ( p value < 0.05) or marginally significant ( p value between 0.05 and 0.1) only for the higher ordered categories of self-reported adherence.

also in 26,082 other papers